Mehmet Asim Bilen

44PUBLICATIONS
269CO-AUTHORS
PharmacogenomicsMolecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|May 25, 2026
Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer.

|May 18, 2026
Dissecting the Tumor Microenvironment to Identify Biomarkers of Outcome to Anti-PD-1 Therapy in Clear-Cell Renal Cell Carcinoma: Analyses of the HCRN GU16-260 Trial.

|Apr 16, 2026
Inflammatory biomarkers have a prognostic role in patients with metastatic castration-resistant prostate cancer treated with Lutetium-177-PSMA-617.

|Dec 16, 2025
Estimated Glomerular Filtration Rate Equations Overestimate Renal Function Compared With Measured Glomerular Filtration Rate Using 24-Hour Urine Creatinine Clearance.

Reza Lahiji, Ernest Allen Morton, Lorenzo Storino Ramacciotti

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Dec 05, 2025
Impact of SPOP Mutations on Clinical Outcomes in Metastatic Prostate Cancer.

Deepak Kilari, Nicholas C Henderson, Kyra Yamamoto

Pageof 8

Frequent Collaborators

6 joint publications

Rana R McKay

5 joint publications

Michael B Atkins

5 joint publications

Vadim S Koshkin

4 joint publications

Andrew J Armstrong